US 9725453
Imidazotriazinone compounds
granted A61PA61P25/00
Quick answer
US patent 9725453 (Imidazotriazinone compounds) held by IRONWOOD PHARMACEUTICALS, INC. expires Mon Aug 03 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- IRONWOOD PHARMACEUTICALS, INC.
- Grant date
- Tue Aug 08 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 03 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 2
- CPC classes
- A61P, A61P25/00